The DC Mother-Infant Behavioral Wellness Program
Advancing Perinatal Mental Health and Well-Being: The DC Mother-Infant Behavioral Wellness Program
1 other identifier
interventional
700
1 country
1
Brief Summary
This randomized controlled study will examine the effectiveness of patient navigation with culturally adapted cognitive-behavioral interventions and peer support groups for low-income Black/of African Descent pregnant women who are experiencing stress, anxiety, and/or depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2022
CompletedFirst Posted
Study publicly available on registry
April 26, 2022
CompletedStudy Start
First participant enrolled
August 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
July 24, 2025
July 1, 2025
4.3 years
March 2, 2022
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Stress at 24 weeks of pregnancy to 12 months postpartum
Perceived Stress Scale: A 10-item questionnaire to measure the self-reported level of stress in the respondents by assessing feelings and thoughts during the last month. Each item is scored from 0 (never) to 5 (very often) with a range of 0 to 40 for the total score of the scale. A higher level of stress is indicated by higher scores on this scale.
Stress will be measured at 24 weeks of pregnancy through infant age of 12 months
Change in Depression at 24 weeks of pregnancy to 12 months postpartum
Edinburgh Postnatal Depression Scale: A 10-item scale used to indicate whether a parent has symptoms that are common in women with depression during pregnancy and in the year following the birth of a child. Each item is scored from 0 (As much as I ever did) to 3 (Not at all) with a range of 0 to 30. Higher level of depression is indicated by a higher score on this scale.
2nd Obstetrics visit (assessed 24-28 weeks gestation) through 12 months postpartum
Change in Anxiety at 24 weeks of pregnancy to 12 months postpartum
General Anxiety Disorder-7 (GAD-7): A 7-item scale to measure levels of anxiety in respondents by assessing feelings and thoughts over the past 2 weeks. Each item is scored from 0 (Not at all) to 3 (Nearly every day) with a range of 0 to 21. Higher level of depression is indicated by a higher score on this scale.
2nd Obstetrics visit (assessed 24-28 weeks gestation) through 12 months postpartum
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants will participate in usual prenatal care throughout the duration of study.
Patient Navigation and treatment
EXPERIMENTALIn the patient navigation arm, women who do not meet diagnostic criteria (Group 2a) can participate in: (1) group-based CBT preventative intervention; (2) peer support group (virtual); or (3) both. Women in the threshold risk group, meeting diagnostic criteria for depression/anxiety (Group 2b) at baseline can participate in: (1) individual CBT treatment (2) peer support group (virtual) (3) both Prevention group includes 8 sessions based on culturally adapted CBT for Black/ of African descent populations facilitated by mental health professionals. Individual treatment includes 12 sessions based on culturally adapted CBT for Black/ of African descent populations.
Interventions
Participants in arm 2 will receive patient navigation provided by humans (rather than e-navigation) to provide personalized care to include support, resources, and referrals to address psychosocial issues that arise during the perinatal period. Patient navigation is available to participants through 12 months postpartum.
Participants who do not meet diagnostic criteria (Group 2a) will participate in a prevention group which includes 8 sessions based on culturally adapted CBT for Black/ of African descent populations facilitated by mental health professionals. Participants who meet diagnostic criteria (Group 2b) will participate in individual treatment which includes 12 sessions based on culturally adapted CBT for Black/ of African descent populations.
Eligibility Criteria
You may qualify if:
- Black/of African Descent
- Pregnant (gestational weeks ≤ 28 weeks)
- Age 18-45
- English proficient
- Receiving services in 1 of 4 study sites above
- Low-income: i.e., receiving Medicaid
- Subthreshold or threshold risk for maternal distress (stress, depression, and/or anxiety)
- Able to provide consent
You may not qualify if:
- age \<18
- Currently under the influence of a substance(s)
- Experiencing psychosis
- Critical (clinical) risk: actively suicidal or homicidal
- Not Black/of African Descent
- Planning to deliver outside DC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's National Research Institutelead
- George Washington Universitycollaborator
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (1)
Unity Healthcare - Brentwood
Washington D.C., District of Columbia, 20018, United States
Related Publications (1)
Le HN, Andescavage N, Keller JM, Bassa MM, Danielson AL, Henderson D, Bond S, Mjenga N, Wells S, Quinn P, Limperopoulos C. Protocol for a randomized controlled trial of the Mommy&Me study: A multi-modal approach to address social determinants of health and mental health among low-income Black perinatal populations. Contemp Clin Trials Commun. 2025 Apr 21;45:101489. doi: 10.1016/j.conctc.2025.101489. eCollection 2025 Jun.
PMID: 40336702DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- None (Open Label)
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Developing Brain Institute and Director of the Advanced Pediatric Brain Imaging Research Program
Study Record Dates
First Submitted
March 2, 2022
First Posted
April 26, 2022
Study Start
August 22, 2022
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
July 24, 2025
Record last verified: 2025-07